Petros Pharmaceuticals, Inc. - Common Stock (PTPI)
0.0130
-0.0449 (-77.55%)
NASDAQ · Last Trade: Apr 30th, 3:33 AM EDT
Detailed Quote
Previous Close
0.0579
Open
0.0400
Bid
0.0182
Ask
0.0183
Day's Range
0.0125 - 0.0400
52 Week Range
0.0125 - 0.7664
Volume
472,155,662
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
41,587,918
Chart
About Petros Pharmaceuticals, Inc. - Common Stock (PTPI)
Petros Pharmaceuticals Inc is a company focused on developing and commercializing innovative pharmaceutical solutions primarily aimed at addressing the needs of men’s health, particularly in the areas of erectile dysfunction and related health issues. The company is dedicated to improving the quality of life for men through its product offerings, which include prescription medications designed to enhance sexual performance and overall well-being. By leveraging scientific research and a commitment to patient care, Petros Pharmaceuticals seeks to provide effective treatment options that empower men to take control of their health and relationships. Read More
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
